127 related articles for article (PubMed ID: 17130787)
1. Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation.
Fang L; Lange C; Engel M; Zander AR; Fehse B
Transplantation; 2006 Nov; 82(10):1370-3. PubMed ID: 17130787
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
3. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
[TBL] [Abstract][Full Text] [Related]
4. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients.
Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Alwayn IP; Weimar W; Hoogduijn MJ
Transplantation; 2009 Mar; 87(6):896-906. PubMed ID: 19300194
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of fetal and adult mesenchymal stem cells.
Le Blanc K
Cytotherapy; 2003; 5(6):485-9. PubMed ID: 14660044
[TBL] [Abstract][Full Text] [Related]
6. Cord blood-derived mesenchymal stem cell does not stimulate nor inhibits T lymphocytes activation.
Tong CK; Seow HF; Ramasamy R
Med J Malaysia; 2008 Jul; 63 Suppl A():77-8. PubMed ID: 19024992
[TBL] [Abstract][Full Text] [Related]
7. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
8. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
9. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
[TBL] [Abstract][Full Text] [Related]
10. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
[TBL] [Abstract][Full Text] [Related]
11. In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them.
Suva D; Passweg J; Arnaudeau S; Hoffmeyer P; Kindler V
J Cell Physiol; 2008 Mar; 214(3):588-94. PubMed ID: 17786951
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells stimulate antibody secretion in human B cells.
Rasmusson I; Le Blanc K; Sundberg B; Ringdén O
Scand J Immunol; 2007 Apr; 65(4):336-43. PubMed ID: 17386024
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation.
Sioud M; Mobergslien A; Boudabous A; Fløisand Y
Scand J Immunol; 2010 Apr; 71(4):267-74. PubMed ID: 20384870
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function.
Renner P; Eggenhofer E; Rosenauer A; Popp FC; Steinmann JF; Slowik P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
Transplant Proc; 2009; 41(6):2607-11. PubMed ID: 19715984
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.
Djouad F; Charbonnier LM; Bouffi C; Louis-Plence P; Bony C; Apparailly F; Cantos C; Jorgensen C; Noël D
Stem Cells; 2007 Aug; 25(8):2025-32. PubMed ID: 17510220
[TBL] [Abstract][Full Text] [Related]
16. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells.
Jones BJ; Brooke G; Atkinson K; McTaggart SJ
Placenta; 2007; 28(11-12):1174-81. PubMed ID: 17714779
[TBL] [Abstract][Full Text] [Related]
18. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.
Lange C; Cakiroglu F; Spiess AN; Cappallo-Obermann H; Dierlamm J; Zander AR
J Cell Physiol; 2007 Oct; 213(1):18-26. PubMed ID: 17458897
[TBL] [Abstract][Full Text] [Related]
19. A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells.
Martinet L; Fleury-Cappellesso S; Gadelorge M; Dietrich G; Bourin P; Fournié JJ; Poupot R
Eur J Immunol; 2009 Mar; 39(3):752-62. PubMed ID: 19197941
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
